Role of enterohepatic recirculation in drug disposition: cooperation and complications

References

• Abou-El-Makarem MM, Millburn P, Smith RL, Williams RT. (1967). Biliary excretion in foreign compounds. Species difference in biliary excretion. Biochem J 105:1289–1293.
   PubMed Web of Science ®Google Scholar
• Abshagen U, Von Grodzicki U, Hirschberger U, Rennekamp H. (1977). Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man. Naunyn Schmiedebergs Arch Pharmacol 300:281–287.
   PubMed Web of Science ®Google Scholar
• Abu-Hayyeh S, Papacleovoulou G, Williamson C. (2013). Nuclear receptors, bile acids and cholesterol homeostasis series – Bile acids and pregnancy. Mol Cell Endocrinol 368:120–128.
   PubMed Web of Science ®Google Scholar
• Adedoyin A, Arns PA, Richards WO, et al. (1998). Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6. Clin Pharmacol Ther 64:8–17.
   PubMed Web of Science ®Google Scholar
• Adkin DA, Davis SS, Sparrow RA, et al. (1995). The effect of different concentrations of mannitol in solution on small intestinal transit: Implications for drug absorption. Pharm Res 12:393–396.
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Martin F. (1980). Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 13:231–244.
   PubMedGoogle Scholar
• Adlercreutz H, Martin F, Jarvenpaa P, Fotsis T. (1979). Steroid absorption and enterohepatic recycling. Contraception 20:201–223.
   PubMed Web of Science ®Google Scholar
• Akita H, Suzuki H, Ito K, et al. (2001). Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 1511:7–16.
   PubMed Web of Science ®Google Scholar
• Aldini R, Roda A, Labate AM, et al. (1982). Hepatic bile acid uptake: Effect of conjugation, hydroxyl and keto groups, and albumin binding. J Lipid Res 23:1167–1173.
   PubMed Web of Science ®Google Scholar
• Aldini R, Roda A, Simoni P, et al. (1989). Uptake of bile acids by perfused rat liver: Evidence of a structure-activity relationship. Hepatology 10:840–845.
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Lopez-Ortega S, Lopez-Vega MC, et al. (2008). Idiosyncratic drug hepatotoxicity: A 2008 update. Expert Rev Clin Pharmacol 1:261–276.
   PubMedGoogle Scholar
• Annaert PP, Turncliff RZ, Booth CL, et al. (2001). P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277–1283.
   PubMed Web of Science ®Google Scholar
• Araujo RG, Casella Filho A, Chagas AC. (2005). Ezetimibe – Pharmacokinetics and therapeutics. Arq Bras Cardiol 85:20–24.
   PubMedGoogle Scholar
• Arboleda RN, Schneider BG, Bravo LE, et al. (2013). Use of the noninvasive entero-test in the detection of Helicobacter pylori in children in an endemic area in Colombia. J Pediatr Gastroenterol Nutr 57:192–196.
   PubMed Web of Science ®Google Scholar
• Arbuck SG, Douglass HO, Crom WR, et al. (1986). Etoposide pharmacokinetics in patients with normal and abnormal organ function. J Clin Oncol 4:1690–1695.
   PubMed Web of Science ®Google Scholar
• Atcheson BA, Taylor PJ, Mudge DW, et al. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br J Clin Pharmacol 59:271–280.
   PubMed Web of Science ®Google Scholar
• Aw MM, Brown NW, Itsuka T, et al. (2003). Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients. Liver Transpl 9:383–388.
   PubMed Web of Science ®Google Scholar
• Back DJ, Bates M, Breckenridge AM, et al. (1981a). The pharmacokinetics of levonorgestrel and ethynylestradiol in women – Studies with Ovran and Ovranette. Contraception 23:229–239.
   PubMed Web of Science ®Google Scholar
• Back DJ, Breckenridge AM, Challiner M, et al. (1978). The effect of antibiotics on the enterohepatic circulation of ethinylestradiol and norethisterone in the rat. J Steroid Biochem 9:527–531.
   PubMedGoogle Scholar
• Back DJ, Breckenridge AM, Crawford FE, et al. (1980). Reduction of the enterohepatic circulation of norethisterone by antibiotics in the rat: Correlation with changes in the gut flora. J Steroid Biochem 13:95–100.
   PubMedGoogle Scholar
• Back DJ, Breckenridge AM, Crawford FE, et al. (1981b). The pharmacokinetics of oestrone sulphate in the rat. J Steroid Biochem 14:1045–1047.
   PubMedGoogle Scholar
• Back DJ, Breckenridge AM, Maciver M, et al. (1982). The effects of ampicillin on oral contraceptive steroids in women. Br J Clin Pharmacol 14:43–48.
   PubMed Web of Science ®Google Scholar
• Back DJ, Grimmer SF, Orme ML, et al. (1988). Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol 25:527–532.
   PubMed Web of Science ®Google Scholar
• Balabaud C, Saric J, Gonzalez P, Delphy C. (1981). Bile collection in free moving rats. Lab Anim Sci 31:273–275.
   PubMedGoogle Scholar
• Barton HA, Lai Y, Goosen TC, et al. (2013). Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: Preclinical, clinical and beyond. Expert Opin Drug Metab Toxicol 9:459–472.
   PubMed Web of Science ®Google Scholar
• Barza M, Weinstein L. (1976). Pharmacokinetics of the penicillins in man. Clin Pharmacokinet 1:297–308.
   PubMedGoogle Scholar
• Beaufort TM, Proost JH, Maring J, et al. (2001). Effect of hypothermia on the hepatic uptake and biliary excretion of vecuronium in the isolated perfused rat liver. Anesthesiology 94:270–279.
   PubMed Web of Science ®Google Scholar
• Bellward GD, Warren PM, Howald W, et al. (1977). Methadone maintenance: Effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther 22:92–99.
   PubMed Web of Science ®Google Scholar
• Berg AK, Mandrekar SJ, Ziegler KL, et al. (2013). Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects. J Clin Pharmacol 53:403–412.
   PubMed Web of Science ®Google Scholar
• Bergman E, Forsell P, Tevell A, et al. (2006). Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. Eur J Pharm Sci 29:205–214.
   PubMed Web of Science ®Google Scholar
• Bergman E, Hedeland M, Bondesson U, Lennernas H. (2010). The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo. Xenobiotica 40:558–568.
   PubMed Web of Science ®Google Scholar
• Bergman E, Lundahl A, Fridblom P, et al. (2009). Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil. Drug Metab Dispos 37:2349–2358.
   PubMed Web of Science ®Google Scholar
• Berry MN, Grivell AR, Grivell M, Phillips JW. (1997). Isolated hepatocytes-past, present and future. Cell Biol Toxicol 13:223–233.
   PubMed Web of Science ®Google Scholar
• Biehl ML, Prelusky DB, Koritz GD, et al. (1993). Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol Appl Pharmacol 121:152–159.
   PubMed Web of Science ®Google Scholar
• Blaschke TF, Rubin PC. (1979). Hepatic first-pass metabolism in liver disease. Clin Pharmacokinet 4:423–432.
   PubMed Web of Science ®Google Scholar
• Blom A, Scaf AH, Meijer DK. (1982). Hepatic drug transport in the rat. A comparison between isolated hepatocytes, the isolated perfused liver and the liver in vivo. Biochem Pharmacol 31:1553–1565.
   PubMed Web of Science ®Google Scholar
• Bohme M, Buchler M, Muller M, Keppler D. (1993). Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 333:193–196.
   PubMed Web of Science ®Google Scholar
• Bohme M, Jedlitschky G, Leier I, et al. (1994). ATP-dependent export pumps and their inhibition by cyclosporins. Adv Enzyme Regul 34:371–380.
   PubMedGoogle Scholar
• Booth CL, Brouwer KR, Brouwer KL. (1998). Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver. Cancer Res 58:3641–3648.
   PubMed Web of Science ®Google Scholar
• Borst P, Elferink RO. (2002). Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592.
   PubMed Web of Science ®Google Scholar
• Bosma PJ, Chowdhury JR, Bakker C, et al. (1995). The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171–1175.
   PubMed Web of Science ®Google Scholar
• Boyer JL. (1986). Mechanisms of bile secretion and hepatic transport. In: Andreoli TE, Fanestil DD, Hoffman JF, eds. Physiology of membrane disorders. 2nd ed. New York: Plenum Medical Book Company, 609–636.
   Google Scholar
• Boyer JL. (2013). Bile formation and secretion. Compr Physiol 3:1035–1078.
   PubMed Web of Science ®Google Scholar
• Bredberg U, Paalzow L. (1990). Pharmacokinetics of methylergometrine in the rat: Evidence for enterohepatic recirculation by a linked-rat model. Pharm Res 7:14–20.
   PubMed Web of Science ®Google Scholar
• Brodersen R. (1979). Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem 254:2364–2369.
   PubMed Web of Science ®Google Scholar
• Brogard JM, Kopferschmitt J, Arnaud JP, et al. (1980). Biliary elimination of mezlocillin: An experimental and clinical study. Antimicrob Agents Chemother 18:69–76.
   PubMed Web of Science ®Google Scholar
• Brown NW, Aw MM, Mieli-Vergani G, et al. (2002). Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: Effect of cyclosporine and tacrolimus comedication. Ther Drug Monit 24:598–606.
   PubMed Web of Science ®Google Scholar
• Brune K, Nuernberg B, Schneider HT. (1993). Biliary elimination of aspirin after oral and intravenous administration in patients. Agents Actions Suppl 44:51–57.
   PubMedGoogle Scholar
• Buchler M, Lebranchu Y, Beneton M, et al. (2005). Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment. Clin Pharmacol Ther 78:34–42.
   PubMed Web of Science ®Google Scholar
• Bui K, She F, Sostek M. (2014). The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol. J Clin Pharmacol 54:1368–1374.
   PubMed Web of Science ®Google Scholar
• Bullingham RE, Nicholls AJ, Kamm BR. (1998). Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34:429–455.
   PubMed Web of Science ®Google Scholar
• Burmester E, Niehaus J, Leineweber T, Huetteroth T. (2003). EUS-cholangio-drainage of the bile duct: Report of 4 cases. Gastrointest Endosc 57:246–251.
   PubMed Web of Science ®Google Scholar
• Byrne JA, Strautnieks SS, Mieli-Vergani G, et al. (2002). The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors. Gastroenterology 123:1649–1658.
   PubMed Web of Science ®Google Scholar
• Cai JS, Chen JH. (2014). The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol 247:1067–1082.
   PubMed Web of Science ®Google Scholar
• Caldwell JH, Bush CA, Greenberger NJ. (1971). Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man. J Clin Invest 50:2638–2644.
   PubMed Web of Science ®Google Scholar
• Caldwell JH, Cline CT. (1976). Biliary excretion of digoxin in man. Clin Pharmacol Ther 19:410–415.
   PubMed Web of Science ®Google Scholar
• Cali JJ, Russell DW. (1991). Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 266:7774–7778.
   PubMed Web of Science ®Google Scholar
• Carriaga MT, Henson DE. (1995). Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75:171–190.
   PubMed Web of Science ®Google Scholar
• Chabot GG, Abigerges D, Catimel G, et al. (1995). Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. Ann Oncol 6:141–151.
   PubMed Web of Science ®Google Scholar
• Challa VR, Babu PR, Challa SR, et al. (2013). Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 39:865–872.
   PubMed Web of Science ®Google Scholar
• Chang Y, Burckart GJ, Lesko LJ, Dowling TC. (2013). Evaluation of hepatic impairment dosing recommendations in FDA-approved product labels. J Clin Pharmacol 53:962–966.
   PubMed Web of Science ®Google Scholar
• Chen HS, Gross JF. (1979). Pharmacokinetics of drugs subject to enterohepatic circulation. J Pharm Sci 68:792–794.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Huang SM, Liu CY, et al. (2008). Hepatobiliary excretion and enterohepatic circulation of colchicine in rats. Int J Pharm 350:230–239.
   PubMed Web of Science ®Google Scholar
• Cheng H, Schwartz MS, Vickers S, et al. (1994). Metabolic disposition of simvastatin in patients with T-tube drainage. Drug Metab Dispos 22:139–142.
   PubMed Web of Science ®Google Scholar
• Chipman JK, Cropper NC. (1977). A technique for chronic intermittent bile collection from the rat. Res Vet Sci 22:366–370.
   PubMed Web of Science ®Google Scholar
• Chowdhury NR, Chowdhury JR, (2001). Disorders of bilirubin metabolism. In: Arias IM, Wolkoff A, Boyer J, Shafritz D, Fausto N, Alter H, Cohen D, eds. The liver: Biology and pathobiology. 5th ed. Malden, MA: Wiley-Blackwell, 251–256.
   Google Scholar
• Clark AG, Cooke R. (1978). The effect of route of administration on the biliary excretion of phenolphthalein and its glucuronide. J Pharm Pharmacol 30:383–383.
   PubMedGoogle Scholar
• Claudel T, Staels B, Kuipers F. (2005). The Farnesoid X receptor: A molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25:2020–2030.
   PubMed Web of Science ®Google Scholar
• Clements MR, Chalmers TM, Fraser DR. (1984). Enterohepatic circulation of vitamin D: A reappraisal of the hypothesis. Lancet 1:1376–1379.
   PubMed Web of Science ®Google Scholar
• Colburn WA, Hirom PC, Parker RJ, Milburn P. (1979). A pharmacokinetic model for enterohepatic recirculation in the rat: Phenolphthalein, a model drug. Drug Metab Dispos 7:100–102.
   PubMed Web of Science ®Google Scholar
• Collins BJ, Grizzle TB, Dunnick JK. (2000). Toxicokinetics of phenolphthalein in male and female rats and mice. Toxicol Sci 56:271–281.
   PubMed Web of Science ®Google Scholar
• Cowling P, Rogers S, Mcmullin CM, et al. (1991). The pharmacokinetics of lomefloxacin in elderly patients with urinary tract infection following daily dosing with 400 mg. J Antimicrob Chemother 28:101–107.
   PubMed Web of Science ®Google Scholar
• Cremers S, Schoemaker R, Scholten E, et al. (2005). Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling. Br J Clin Pharmacol 60:249–256.
   PubMed Web of Science ®Google Scholar
• Cui Y, Konig J, Keppler D. (2001). Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 60:934–943.
   PubMed Web of Science ®Google Scholar
• Dahlstrom BE, Paalzow LK. (1978). Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J Pharmacokinet Biopharm 6:505–519.
   PubMedGoogle Scholar
• Davi H, Tronquet C, Miscoria G, et al. (2000). Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques. Drug Metab Dispos 28:79–88.
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
   PubMed Web of Science ®Google Scholar
• Davies NM, Takemoto JK, Brocks DR, Yanez JA. (2010). Multiple peaking phenomena in pharmacokinetic disposition. Clin Pharmacokinet 49:351–377.
   PubMed Web of Science ®Google Scholar
• Davies NM, Wallace JL. (1997). Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: New insights into an old problem. J Gastroenterol 32:127–133.
   PubMed Web of Science ®Google Scholar
• Davis TM, Daly F, Walsh JP, et al. (2000). Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br J Clin Pharmacol 49:223–230.
   PubMed Web of Science ®Google Scholar
• Dawson S, Stahl S, Paul N, et al. (2012). In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130–138.
   PubMed Web of Science ®Google Scholar
• De Jong FA, Scott-Horton TJ, Kroetz DL, et al. (2007). Irinotecan-induced diarrhea: Functional significance of the polymorphic ABCC2 transporter protein. Clin Pharmacol Ther 81:42–49.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhuang X, Shen G, et al. (2012). Biliary excretion and enterohepatic circulation of thienorphine and its glucuronide conjugate in rats. Acta Pharm Sin B 2:174–180.
   Google Scholar
• Deo AK, Prasad B, Balogh L, et al. (2012). Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): Quantification by liquid chromatography/tandem mass spectrometry. Drug Metab Dispos 40:852–855.
   PubMed Web of Science ®Google Scholar
• Doherty MM, Pang KS. (1997). First-pass effect: Significance of the intestine for absorption and metabolism. Drug Chem Toxicol 20:329–344.
   PubMed Web of Science ®Google Scholar
• Drescher S, Glaeser H, Murdter T, et al. (2003). P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin Pharmacol Ther 73:223–231.
   PubMed Web of Science ®Google Scholar
• Duane WC, Levitt DG, Mueller SM, Behrens JC. (1983). Regulation of bile acid synthesis in man. Presence of a diurnal rhythm. J Clin Invest 72:1930–1936.
   PubMed Web of Science ®Google Scholar
• Duez H, Van Der Veen JN, Duhem C, et al. (2008). Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology 135:689–698.
   PubMed Web of Science ®Google Scholar
• Edmiston CE, Jr, Suarez EC, Walker AP, et al. (1996). Penetration of ciprofloxacin and fleroxacin into biliary tract. Antimicrob Agents Chemother 40:787–791.
   PubMed Web of Science ®Google Scholar
• Eeckhoudt SL, Evrard PA, Verbeeck RK. (1997). Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat. Drug Metab Dispos 25:428–430.
   PubMed Web of Science ®Google Scholar
• Eggertsen G, Olin M, Andersson U, et al. (1996). Molecular cloning and expression of rabbit sterol 12alpha-hydroxylase. J Biol Chem 271:32269–32275.
   PubMed Web of Science ®Google Scholar
• Elaut G, Vanhaecke T, Heyden YV, Rogiers V. (2005). Spontaneous apoptosis, necrosis, energy status, glutathione levels and biotransformation capacities of isolated rat hepatocytes in suspension: Effect of the incubation medium. Biochem Pharmacol 69:1829–1838.
   PubMed Web of Science ®Google Scholar
• Elmquist WF, Sawchuk RJ. (1997). Application of microdialysis in pharmacokinetic studies. Pharm Res 14:267–288.
   PubMed Web of Science ®Google Scholar
• Elomaa K, Ranta S, Tuominen J, Lahteenmaki P. (2001a). Charcoal treatment and risk of escape ovulation in oral contraceptive users. Hum Reprod 16:76–81.
   PubMed Web of Science ®Google Scholar
• Elomaa K, Ranta S, Tuominen J, Lahteenmaki P. (2001b). The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. Contraception 63:13–18.
   PubMed Web of Science ®Google Scholar
• Erlinger S. (1996). Review article: New insights into the mechanisms of hepatic transport and bile secretion. J Gastroenterol Hepatol 11:575–579.
   PubMed Web of Science ®Google Scholar
• Ezzet F, Krishna G, Wexler DB, et al. (2001). A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ther 23:871–885.
   PubMed Web of Science ®Google Scholar
• Fabre J, Pitton JS, Virieux C, et al. (1967). Doxycycline. Absorption, distribution and excretion of a new broad spectrum antibiotic in man. Schweiz Med Wochenschr 97:915–924.
   PubMedGoogle Scholar
• Fagerholm U. (2008). Prediction of human pharmacokinetics – Biliary and intestinal clearance and enterohepatic circulation. J Pharm Pharmacol 60:535–542.
   PubMed Web of Science ®Google Scholar
• Farmer JA. (2001). Learning from the cerivastatin experience. Lancet. 358:1383–1385.
   PubMed Web of Science ®Google Scholar
• Fattinger K, Funk C, Pantze M, et al. (2001). The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69:223–231.
   PubMed Web of Science ®Google Scholar
• Ferenci P, Grimm G, Meryn S, Gangl A. (1989). Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96:240–243.
   PubMed Web of Science ®Google Scholar
• Ferguson KJ, Yesalis CE, Pomrehn PR, Kirkpatrick MB. (1989). Attitudes, knowledge, and beliefs as predictors of exercise intent and behavior in schoolchildren. J Sch Health 59:112–115.
   PubMed Web of Science ®Google Scholar
• Ferrebee CB, Dawson PA. (2015). Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids. Acta Pharm Sin B 5:129–134.
   PubMed Web of Science ®Google Scholar
• Filler G, Lepage N, Delisle B, Mai I. (2001). Effect of cyclosporine on mycophenolic acid area under the concentration-time curve in pediatric kidney transplant recipients. Ther Drug Monit 23:514–519.
   PubMed Web of Science ®Google Scholar
• Filler G, Zimmering M, Mai I. (2000). Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Pediatr Nephrol 14:100–104.
   PubMed Web of Science ®Google Scholar
• Fortun PJ, Hawkey CJ. (2007). Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 23:134–141.
   PubMed Web of Science ®Google Scholar
• Frye RF, Zgheib NK, Matzke GR, et al. (2006). Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin Pharmacol Ther 80:235–245.
   PubMed Web of Science ®Google Scholar
• Fu S, Rowe A, Ramzan I. (2012). Kavalactone metabolism in the isolated perfused rat liver. Phytother Res 26:1813–1816.
   PubMed Web of Science ®Google Scholar
• Funaki T. (1999). Enterohepatic circulation model for population pharmacokinetic analysis. J Pharm Pharmacol 51:1143–1148.
   PubMed Web of Science ®Google Scholar
• Funk C, Ponelle C, Scheuermann G, Pantze M. (2001). Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59:627–635.
   PubMed Web of Science ®Google Scholar
• Funk RS, Brown JT, Abdel-Rahman SM. (2012). Pediatric pharmacokinetics: Human development and drug disposition. Pediatr Clin North Am 59:1001–1016.
   PubMed Web of Science ®Google Scholar
• Gabrielsson JL, Weiner DL. (1999). Methodology for pharmacokinetic/pharmacodynamic data analysis. Pharm Sci Technol Today 2:244–252.
   PubMedGoogle Scholar
• Galatola G, Jazrawi RP, Bridges C, et al. (1991). Direct measurement of first-pass ileal clearance of a bile acid in humans. Gastroenterology 100:1100–1105.
   PubMed Web of Science ®Google Scholar
• Gantla S, Bakker CT, Deocharan B, et al. (1998). Splice-site mutations: A novel genetic mechanism of Crigler-Najjar syndrome type 1. Am J Hum Genet 62:585–592.
   PubMed Web of Science ®Google Scholar
• Gao Y, Shao J, Jiang Z, et al. (2014). Drug enterohepatic circulation and disposition: Constituents of systems pharmacokinetics. Drug Discov Today 19:326–340.
   PubMed Web of Science ®Google Scholar
• Garbutt JT, Heaton KW, Lack L, Tyor MP. (1969). Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders. Gastroenterology 56:711–720.
   PubMed Web of Science ®Google Scholar
• Garbutt JT, Kenney TJ. (1972). Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest 51:2781–2789.
   PubMed Web of Science ®Google Scholar
• Garg DC, Weidler DJ, Eshelman FN. (1983). Ranitidine bioavailability and kinetics in normal male subjects. Clin Pharmacol Ther 33:445–452.
   PubMed Web of Science ®Google Scholar
• Garnock-Jones KP. (2015). Naloxegol: A review of its use in patients with opioid-induced constipation. Drugs 75:419–425.
   PubMed Web of Science ®Google Scholar
• George J, Murray M, Byth K, Farrell GC. (1995). Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 21:120–128.
   PubMed Web of Science ®Google Scholar
• Gerk PM, Vore M. (2002). Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 302:407–415.
   PubMed Web of Science ®Google Scholar
• Ghibellini G, Johnson BM, Kowalsky RJ, et al. (2004). A novel method for the determination of biliary clearance in humans. AAPS J 6:e33.
   PubMedGoogle Scholar
• Ghibellini G, Leslie EM, Brouwer KL. (2006). Methods to evaluate biliary excretion of drugs in humans: An updated review. Mol Pharm 3:198–211.
   PubMed Web of Science ®Google Scholar
• Glass GB, Mersheimer WL. (1960). Metabolic turnover of vitamin B12 in the normal and diseased liver. Am J Clin Nutr 8:285–292.
   PubMed Web of Science ®Google Scholar
• Godfrey KR, Arundel PA, Dong Z, Bryant R. (2011). Modelling the double peak phenomenon in pharmacokinetics. Comput Methods Programs Biomed 104:62–69.
   PubMed Web of Science ®Google Scholar
• Goldin BR, Adlercreutz H, Gorbach SL, et al. (1982). Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 307:1542–1547.
   PubMed Web of Science ®Google Scholar
• Goldsmith RS. (1982). Enterohepatic cycling of vitamin D and its metabolites. Miner Electrolyte Metab 8:289–292.
   PubMedGoogle Scholar
• Gorbach SL, Goldin BR. (1987). Diet and the excretion and enterohepatic cycling of estrogens. Prev Med 16:525–531.
   PubMed Web of Science ®Google Scholar
• Gramatte T, El Desoky E, Klotz U. (1994). Site-dependent small intestinal absorption of ranitidine. Eur J Clin Pharmacol 46:253–259.
   PubMed Web of Science ®Google Scholar
• Granero GE, Amidon GL. (2008). Possibility of enterohepatic recycling of ketoprofen in dogs. Int J Pharm 349:166–171.
   PubMed Web of Science ®Google Scholar
• Grime K, Paine SW. (2013). Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement. Drug Metab Dispos 41:372–378.
   PubMed Web of Science ®Google Scholar
• Groen AK, Van Wijland MJ, Frederiks WM, et al. (1995). Regulation of protein secretion into bile: Studies in mice with a disrupted mdr2 p-glycoprotein gene. Gastroenterology 109:1997–2006.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Metzger AL. (1972). A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200–1217.
   PubMed Web of Science ®Google Scholar
• Guiney WJ, Beaumont C, Thomas SR, et al. (2011). Use of Entero-Test, a simple approach for non-invasive clinical evaluation of the biliary disposition of drugs. Br J Clin Pharmacol 72:133–142.
   PubMed Web of Science ®Google Scholar
• Gundert-Remy U, Forster D, Schacht P, Weber E. (1982a). Kinetics of mezlocillin in patients with biliary t-tube drainage. J Antimicrob Chemother 9:65–75.
   PubMed Web of Science ®Google Scholar
• Gundert-Remy U, Frohnapfel F, Jourdan W, et al. (1982b). Estimation of biliary excretion of ureidopenicillins in healthy volunteers using marker dilution technique. Br J Clin Pharmacol 13:795–801.
   PubMed Web of Science ®Google Scholar
• Gustavson LE, Mengel HB. (1995). Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses. Epilepsia 36:605–611.
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Gui C. (2008). Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:778–801.
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Meier PJ. (1996). Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin Liver Dis 16:129–136.
   PubMed Web of Science ®Google Scholar
• Halilovic J, Heintz BH. (2014). Antibiotic dosing in cirrhosis. Am J Health Syst Pharm 71:1621–1634.
   PubMed Web of Science ®Google Scholar
• Hary L, Andrejak M, Leleu S, et al. (1989). The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites. Eur J Clin Pharmacol 36:613–616.
   PubMed Web of Science ®Google Scholar
• Hasselstrom J, Eriksson S, Persson A, et al. (1990). The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol 29:289–297.
   PubMed Web of Science ®Google Scholar
• Hayes PC, Plevris JN, Bouchier IA. (1989). Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function. J Hum Hypertens 3:153–158.
   PubMed Web of Science ®Google Scholar
• Hazell AS, Butterworth RF. (1999). Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 222:99–112.
   PubMed Web of Science ®Google Scholar
• Heimer GM, Englund DE. (1986). Enterohepatic recirculation of oestriol: Inhibition by activated charcoal. Acta Endocrinol (Copenh) 113:93–95.
   PubMedGoogle Scholar
• Heitmeyer SA, Powers JF. (1992). Improved method for bile collection in unrestrained conscious rats. Lab Anim Sci 42:312–315.
   PubMedGoogle Scholar
• Hellstern A, Hildebrand M, Humpel M, et al. (1990). Minimal biliary excretion and enterohepatic recirculation of lormetazepam in man as investigated by a new nasobiliary drainage technique. Int J Clin Pharmacol Ther Toxicol 28:256–261.
   PubMed Web of Science ®Google Scholar
• Hengstler JG, Utesch D, Steinberg P, et al. (2000). Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81–118.
   PubMed Web of Science ®Google Scholar
• Herman RJ, Chaudhary A, Szakacs CB. (1994). Disposition of lorazepam in Gilbert's syndrome: Effects of fasting, feeding, and enterohepatic circulation. J Clin Pharmacol 34:978–984.
   PubMed Web of Science ®Google Scholar
• Herman RJ, Van Pham JD, Szakacs CB. (1989). Disposition of lorazepam in human beings: Enterohepatic recirculation and first-pass effect. Clin Pharmacol Ther 46:18–25.
   PubMed Web of Science ®Google Scholar
• Heubi JE, Setchell KD, Bove KE. (2007). Inborn errors of bile acid metabolism. Semin Liver Dis 27:282–294.
   PubMed Web of Science ®Google Scholar
• Hidaka K, Yamamoto H, Harada S, et al. (1988). Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice. Jpn J Antibiot 41:1295–1303.
   PubMedGoogle Scholar
• Hiller A, Nguyen N, Strassburg CP, et al. (1999). Retigabine N-glucuronidation and its potential role in enterohepatic circulation. Drug Metab Dispos 27:605–612.
   PubMed Web of Science ®Google Scholar
• Hirano M, Maeda K, Hayashi H, et al. (2005). Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther 314:876–882.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM. (2013). Genetic determinants of cholestasis. Clin Liver Dis 17:147–159.
   PubMed Web of Science ®Google Scholar
• Hobbs DC. (1983). Pharmacokinetics of piroxicam in man. Eur J Rheumatol Inflamm 6:46–55.
   PubMed Web of Science ®Google Scholar
• Hoeijmakers M, Janszen B, Coert A, Horspool L. (2003). Pharmacokinetics of oestriol after repeated oral administration to dogs. Res Vet Sci 75:55–59.
   PubMed Web of Science ®Google Scholar
• Hofmann AF. (1976). The enterohepatic circulation of bile acids in man. In: Taylor W, ed. The hepatobiliary system. Berlin: Springer, 517–527.
   Google Scholar
• Hofmann AF, Hagey LR. (2014). Key discoveries in bile acid chemistry and biology and their clinical applications: History of the last eight decades. J Lipid Res 55:1553–1595.
   PubMed Web of Science ®Google Scholar
• Hogben CM. (1971). Biological membranes and their passage by drugs. In: Brodie BB, Gillette JR, Ackerman HS, eds. Concepts in biochemical pharmacology. New York: Springer, 1–8.
   Google Scholar
• Hong G, Bazin-Redureau M, Gires P, Scherrmann JM. (1998). Hepatic disposition and toxicity of cationized goat immunoglobulin G and fab fragments in isolated perfused rat liver. Drug Metab Dispos 26:661–669.
   PubMed Web of Science ®Google Scholar
• Horii Y, Ikenaga M, Shimoda M, Kokue E. (2004). Pharmacokinetics of flunixin in the cat: Enterohepatic circulation and active transport mechanism in the liver. J Vet Pharmacol Ther 27:65–69.
   PubMed Web of Science ®Google Scholar
• Horikawa M, Kato Y, Tyson CA, Sugiyama Y. (2003). Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet 18:16–22.
   PubMedGoogle Scholar
• Hosey CM, Broccatelli F, Benet LZ. (2014). Predicting when biliary excretion of parent drug is a major route of elimination in humans. AAPS J 16:1085–1098.
   PubMed Web of Science ®Google Scholar
• Huang SM, Marriott TB, Weintraub HS, et al. (1988). Clinical pharmacokinetics of etintidine. Biopharm Drug Dispos 9:477–486.
   PubMed Web of Science ®Google Scholar
• Huang YJ, Liao JF, Tsai TH. (2005). Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography. Biomed Chromatogr 19:488–493.
   PubMed Web of Science ®Google Scholar
• Hudson RJ, Thomson IR, Burgess PM, Rosenbloom M. (1991). Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery. Can J Anaesth 38:61–67.
   PubMed Web of Science ®Google Scholar
• Hughes RD, Millburn P, Williams RT. (1973). Molecular weight as a factor in the excretion of monoquaternary ammonium cations in the bile of the rat, rabbit and guinea pig. Biochem J 136:967–978.
   PubMed Web of Science ®Google Scholar
• Huntjens DR, Strougo A, Chain A, et al. (2008). Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. Br J Pharmacol 153:1072–1084.
   PubMed Web of Science ®Google Scholar
• Ibarra M, Vazquez M, Fagiolino P. (2014). Population pharmacokinetic model to analyze nevirapine multiple-peaks profile after a single oral dose. J Pharmacokinet Pharmacodyn 41:363–373.
   PubMed Web of Science ®Google Scholar
• Ichikawa R, Takayama T, Yoneno K, et al. (2012). Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway. Immunology 136:153–162.
   PubMed Web of Science ®Google Scholar
• Iga T, Klaassen CD. (1982). Hepatic extraction of bile acids in rats. Biochem Pharmacol 31:205–209.
   PubMed Web of Science ®Google Scholar
• Ikeuchi N, Itoi T. (2015). Endoscopic ultrasonography (EUS)-guided biliary drainage: An alternative to percutaneous transhepatic puncture. Gastrointest Interv 4:31–39.
   Google Scholar
• Inagaki T, Choi M, Moschetta A, et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217–225.
   PubMed Web of Science ®Google Scholar
• Ishizuka H, Konno K, Shiina T, et al. (1999). Species differences in the transport activity for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 290:1324–1330.
   PubMed Web of Science ®Google Scholar
• Jain AK, Stoll B, Burrin DG, et al. (2012). Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs. Am J Physiol Gastrointest Liver Physiol 302:G218–G224.
   PubMed Web of Science ®Google Scholar
• Jamali F, Berry BW, Tehrani MR, Russell AS. (1988). Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci 77:666–669.
   PubMed Web of Science ®Google Scholar
• Janowitz P, Swobodnik W, Wechsler JG, et al. (1990). Comparison of gall bladder bile and endoscopically obtained duodenal bile. Gut 31:1407–1410.
   PubMed Web of Science ®Google Scholar
• Jeu L, Cheng JW. (2003). Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ther 25:2352–2387.
   PubMed Web of Science ®Google Scholar
• Jiang ZY, Parini P, Eggertsen G, et al. (2008). Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res 49:464–472.
   PubMed Web of Science ®Google Scholar
• Kalser SC, Kelly MP, Forbes EB, Randolph MM. (1969). Drug metabolism in hypothermia. Uptake, metabolism and biliary excretion of pentobarbital-2-C14 by the isolated, perfused rat liver in hypothermia and euthermia. J Pharmacol Exp Ther 170:145–152.
   PubMed Web of Science ®Google Scholar
• Kalser SC, Kelvington EJ, Randolph MM. (1968). Drug metabolism in hypothermia. Uptake, metabolism and excretion of S35-sulfanilamide by the isolated, perfused rat liver. J Pharmacol Exp Ther 159:389–398.
   PubMed Web of Science ®Google Scholar
• Kalser SC, Kelvington EJ, Randolph MM, Santomenna DM. (1965a). Drug metabolism in hypothermia. I. Biliary excretion of C 14-atropine metabolites in the intact and nephrectomized rat. J Pharmacol Exp Ther 147:252–259.
   PubMed Web of Science ®Google Scholar
• Kalser SC, Kelvington EJ, Randolph MM, Santomenna DM. (1965b). Drug metabolism in hypothermia. II. C 14-atropine uptake, metabolism and excretion by the isolated, perfused rat liver. J Pharmacol Exp Ther 147:260–269.
   PubMed Web of Science ®Google Scholar
• Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. (1989). The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 264:11693–11698.
   PubMed Web of Science ®Google Scholar
• Kanazawa S, Herbert V, Herzlich B, et al. (1983). Removal of cobalamin analogue in bile by enterohepatic circulation of vitamin B12. Lancet 1:707–708.
   PubMed Web of Science ®Google Scholar
• Katzung BG, Meyers FH. (1965). Excretion of radioactive digitoxin by the dog. J Pharmacol Exp Ther 149:257–262.
   PubMed Web of Science ®Google Scholar
• Kawakami J, Yamamura Y, Santa T, et al. (1993). Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: Role of enterohepatic circulation. J Pharm Sci 82:301–305.
   PubMed Web of Science ®Google Scholar
• Keitel V, Nies AT, Brom M, et al. (2003). A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 284:G165–G174.
   PubMed Web of Science ®Google Scholar
• Keppler D, Konig J. (2000). Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 20:265–272.
   PubMed Web of Science ®Google Scholar
• Kerkadi A, Barriault C, Marquardt RR, et al. (1999). Cholestyramine protection against ochratoxin A toxicity: Role of ochratoxin A sorption by the resin and bile acid enterohepatic circulation. J Food Prot 62:1461–1465.
   PubMed Web of Science ®Google Scholar
• Kim HG, Lee JH, Lee SJ, et al. (2012). The increased cellular uptake and biliary excretion of curcumin by quercetin: A possible role of albumin binding interaction. Drug Metab Dispos 40:1452–1455.
   PubMed Web of Science ®Google Scholar
• Kim TH, Shin S, Bashir M, et al. (2014). Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats. Xenobiotica 44:913–925.
   PubMed Web of Science ®Google Scholar
• Klaassen CD. (1973). Hepatic excretory function in the newborn rat. J Pharmacol Exp Ther 184:721–728.
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Watkins JB, III. (1984). Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1–67.
   PubMed Web of Science ®Google Scholar
• Kleeberg U, Fishcer E, Gregus Z, et al. (1979). Effect of 3-methylcholanthrene on the biliary excretion of bromsulphthalein and eosine in newborn rats. Acta Physiol Acad Sci Hung 53:363–367.
   PubMedGoogle Scholar
• Klotz U, Antonin KH. (1977). Biliary excretion studies with digoxin in man. Int J Clin Pharmacol Biopharm 15:332–334.
   PubMedGoogle Scholar
• Knutson L, Odlind B, Hallgren R. (1989). A new technique for segmental jejunal perfusion in man. Am J Gastroenterol 84:1278.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Fukushima K, Maeda Y, et al. (2013). Effects of bile duct stricture on the pharmacokinetics of the immunosuppressant tacrolimus in rats. Interact Med Chem 1:1.
   Google Scholar
• Kojima J, Ohshima T, Yoneda M, Sawada H. (2001). Effect of biliary excretion on the pharmacokinetics of pitavastatin (NK-104) in dogs. Drug Metab Pharmacokinet 16:497–502.
   Google Scholar
• Kok T, Hulzebos CV, Wolters H, et al. (2003). Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: Efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 278:41930–41937.
   PubMed Web of Science ®Google Scholar
• Konig J, Nies AT, Cui Y, et al. (1999). Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461:377–394.
   PubMed Web of Science ®Google Scholar
• Konigsson K, Torneke K, Engeland IV, et al. (2003). Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats. Acta Vet Scand 44:153–159.
   PubMed Web of Science ®Google Scholar
• Kopplow K, Letschert K, Konig J, et al. (2005). Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells. Mol Pharmacol 68:1031–1038.
   PubMed Web of Science ®Google Scholar
• Koren G, Barker C, Bohn D, et al. (1985). Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med 13:844–847.
   PubMed Web of Science ®Google Scholar
• Kosoglou T, Statkevich P, Johnson-Levonas AO, et al. (2005). Ezetimibe: A review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44:467–494.
   PubMed Web of Science ®Google Scholar
• Kucera O, Lotkova H, Krivakova P, et al. (2006). Model systems for study of toxic injury of hepatocytes in vitro. Cesk Fysiol 55:103–110.
   PubMedGoogle Scholar
• Kuipers F, Bloks VW, Groen AK. (2014). Beyond intestinal soap-bile acids in metabolic control. Nat Rev Endocrinol 10:488–498.
   PubMed Web of Science ®Google Scholar
• Kuipers F, Havinga R, Bosschieter H, et al. (1985). Enterohepatic circulation in the rat. Gastroenterology 88:403–411.
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Stieger B, Meier PJ. (2004). Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322–342.
   PubMed Web of Science ®Google Scholar
• Kumar D, Khanna AK, Pratap R, et al. (2012). Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone. Indian J Pharmacol 44:57–62.
   PubMed Web of Science ®Google Scholar
• Kumar Jain A, Teckman JH. (2014). Newly identified mechanisms of total parenteral nutrition related liver injury. Adv Hepatol. 2014:493087.
   PubMedGoogle Scholar
• Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. (2003). Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance. Clin Pharmacol Ther 73:538–544.
   PubMed Web of Science ®Google Scholar
• Lai Y. (2009). Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion. Expert Opin Drug Metab Toxicol 5:1175–1187.
   PubMed Web of Science ®Google Scholar
• Laidlaw J, Read AE, Sherlock S. (1961). Morphine tolerance in hepatic cirrhosis. Gastroenterology 40:389–396.
   PubMed Web of Science ®Google Scholar
• Landskroner KA, Hess P, Treiber A. (2011). Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics. Xenobiotica 41:687–700.
   PubMed Web of Science ®Google Scholar
• Lasocki A, Vote B, Fassett R, Zamir E. (2007). Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis. Ocul Immunol Inflamm 15:345–346.
   PubMed Web of Science ®Google Scholar
• Lecureur V, Courtois A, Payen L, et al. (2000). Expression and regulation of hepatic drug and bile acid transporters. Toxicology 153:203–219.
   PubMed Web of Science ®Google Scholar
• Lees P, Pelligand L, Elliott J, et al. (2015). Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: A review. J Vet Pharmacol Ther 38:1–14.
   PubMed Web of Science ®Google Scholar
• Lehr T, Staab A, Tillmann C, et al. (2009). A quantitative enterohepatic circulation model: Development and evaluation with tesofensine and meloxicam. Clin Pharmacokinet 48:529–542.
   PubMed Web of Science ®Google Scholar
• Leng DD, Han WJ, Rui Y, et al. (2013). In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb. J Ethnopharmacol 150:601–608.
   PubMed Web of Science ®Google Scholar
• Lennernas H, Regardh CG. (1993). Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile. Pharm Res 10:879–883.
   PubMed Web of Science ®Google Scholar
• Leung JW, Chan RC, Cheung SW, et al. (1990). The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 25:399–406.
   PubMed Web of Science ®Google Scholar
• Levine WG. (1981). Biliary excretion of drugs and other xenobiotics. Prog Drug Res 25:361–420.
   PubMedGoogle Scholar
• Levison ME, Levison JH. (2009). Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am 23:791–815.
   PubMed Web of Science ®Google Scholar
• Li-Hawkins J, Lund EG, Bronson AD, Russell DW. (2000). Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem 275:16543–16549.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang Y, Xiao L, et al. (2007). Simultaneous determination of harpagoside and cinnamic acid in rat plasma by high-performance liquid chromatography: Application to a pharmacokinetic study. Analyt Bioanalyt Chem 389:2259–2264.
   PubMed Web of Science ®Google Scholar
• Li R, Barton HA, Varma MV. (2014). Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved. Clin Pharmacokinet 53:659–678.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. (2014). Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 66:948–983.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. (2015). Bile acids as metabolic regulators. Curr Opin Gastroenterol 31:159–165.
   PubMed Web of Science ®Google Scholar
• Lin JH. (1995). Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23:1008–1021.
   PubMed Web of Science ®Google Scholar
• Liu A, Krausz KW, Fang ZZ, et al. (2014). Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity. Arch Toxicol 88:983–996.
   PubMed Web of Science ®Google Scholar
• Liu MJ, Pollack GM. (1993). Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid. Biopharm Drug Dispos 14:325–339.
   PubMed Web of Science ®Google Scholar
• Liu X, Chism JP, Lecluyse EL, et al. (1999). Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637–644.
   PubMed Web of Science ®Google Scholar
• Loguidice A, Wallace BD, Bendel L, et al. (2012). Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice . J Pharmacol Exp Ther 341:447–454.
   PubMed Web of Science ®Google Scholar
• Lou Y, Hu H, Liu Y, et al. (2011). Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study. J Pharm Biomed Anal 55:1163–1169.
   PubMed Web of Science ®Google Scholar
• Luke DR, Foulds G, Cohen SF, Levy B. (1996). Safety, toleration, and pharmacokinetics of intravenous azithromycin. Antimicrob Agents Chemother 40:2577–2581.
   PubMed Web of Science ®Google Scholar
• Lundahl A, Lennernas H, Knutson L, et al. (2009). Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry. Drug Metab Dispos 37:2008–2017.
   PubMed Web of Science ®Google Scholar
• Luo G, Johnson S, Hsueh MM, et al. (2010). In silico prediction of biliary excretion of drugs in rats based on physicochemical properties. Drug Metab Dispos 38:422–430.
   PubMed Web of Science ®Google Scholar
• Lyons MA, Reisfeld B, Yang RS, Lenaerts AJ. (2013). A physiologically based pharmacokinetic model of rifampin in mice. Antimicrob Agents Chemother 57:1763–1771.
   PubMed Web of Science ®Google Scholar
• Ma Y, Li P, Chen D, et al. (2006). LC/MS/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma. Int J Pharm 307:292–299.
   PubMed Web of Science ®Google Scholar
• Maeda K, Sugiyama Y. (2008). Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet 23:223–235.
   PubMed Web of Science ®Google Scholar
• Mahmood I. (2005). Interspecies scaling of biliary excreted drugs: A comparison of several methods. J Pharm Sci 94:883–892.
   PubMed Web of Science ®Google Scholar
• Mahmood I. (2012). Interspecies scaling of biliary excreted drugs: Prediction of human clearance and volume of distribution. Drug Metabol Drug Interact 27:157–164.
   PubMedGoogle Scholar
• Mahmood I, Sahajwalla C. (2002). Interspecies scaling of biliary excreted drugs. J Pharm Sci 91:1908–1914.
   PubMed Web of Science ®Google Scholar
• Manautou JE, De Waart DR, Kunne C, et al. (2005). Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology 42:1091–1098.
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, et al. (2002). Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302:369–373.
   PubMed Web of Science ®Google Scholar
• Marinelli RA, Larusso NF. (1996). Solute and water transport pathways in cholangiocytes. Semin Liver Dis 16:221–229.
   PubMed Web of Science ®Google Scholar
• Martinez SE, Sayre CL, Davies NM. (2013). Pharmacometrics of 3-methoxypterostilbene: A component of traditional chinese medicinal plants. Evid Based Complement Alternat Med 2013:261468
   PubMed Web of Science ®Google Scholar
• Matsubara T, Li F, Gonzalez FJ. (2013). FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368:17–29.
   PubMed Web of Science ®Google Scholar
• Matsui H, Takeuchi S, Osada T, et al. (2012). Enhanced bile canaliculi formation enabling direct recovery of biliary metabolites of hepatocytes in 3D collagen gel microcavities. Lab Chip 12:1857–1864.
   PubMed Web of Science ®Google Scholar
• Matsushima S, Maeda K, Kondo C, et al. (2005). Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059–1067.
   PubMed Web of Science ®Google Scholar
• Mcclain DA, Hug CC. Jr. (1980). Intravenous fentanyl kinetics. Clin Pharmacol Ther 28:106–114.
   PubMed Web of Science ®Google Scholar
• Mcginnity DF, Soars MG, Urbanowicz RA, Riley RJ. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos 32:1247–1253.
   PubMed Web of Science ®Google Scholar
• Mclean AJ, Morgan DJ. (1991). Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet 21:42–69.
   PubMed Web of Science ®Google Scholar
• Mcmaster P, Mirza DF, Ismail T, et al. (1995). Therapeutic drug monitoring of tacrolimus in clinical transplantation. Ther Drug Monit 17:602–605.
   PubMed Web of Science ®Google Scholar
• Mcpherson GA, Benjamin IS, Boobis AR, et al. (1982). Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice. Gut 23:734–738.
   PubMed Web of Science ®Google Scholar
• Meier PJ, Stieger B. (2002). Bile salt transporters. Annu Rev Physiol 64:635–661.
   PubMed Web of Science ®Google Scholar
• Meijer DK, Bognacki J, Levine WG. (1975). Effect of nafenopin (SU-13,437) on liver function: Influence on the hepatic transport of organic anions. Naunyn Schmiedebergs Arch Pharmacol 290:235–250.
   PubMed Web of Science ®Google Scholar
• Meinertz T, Gilfrich HJ, Groth U, et al. (1977a). Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine. Clin Pharmacol Ther 21:731–735.
   PubMed Web of Science ®Google Scholar
• Meinertz T, Gilfrich MJ, Bork R, Jahnchen E. (1977b). Treatment of phenprocoumon intoxication with cholestyramine. Br Med J 2:439
   PubMed Web of Science ®Google Scholar
• Melander A. (1987). Clinical pharmacology of sulfonylureas. Metab Clin Exp 36:12–16.
   PubMed Web of Science ®Google Scholar
• Melander A, Wåhlin-Boll E. (1983). Clinical pharmacology of glipizide. Am J Med 75:41–45.
   PubMed Web of Science ®Google Scholar
• Meng LJ, Reyes H, Palma J, et al. (1997). Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol 27:346–357.
   PubMed Web of Science ®Google Scholar
• Metsugi Y, Miyaji Y, Ogawara K, et al. (2008). Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function. Pharm Res 25:886–895.
   PubMed Web of Science ®Google Scholar
• Millburn P, Smith RL, Williams RT. (1967). Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: Molecular weight, polarity and metabolism as factors in biliary excretion. Biochem J 105:1275–1281.
   PubMed Web of Science ®Google Scholar
• Miller RD, Agoston S, Van Der Pol F, et al. (1978). Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharmacol Exp Ther 207:532–538.
   PubMed Web of Science ®Google Scholar
• Mirfazaelian A, Mahmoudian M. (1995). A comprehensive computer programme for evaluation and teaching drug pharmacokinetics. Abst. 12th Iranian Congress on Physiology and Pharmacology, Tehran, Iran; Paper P3-18.
   Google Scholar
• Mirfazaelian A, Mahmoudian M. (2006). A simple pharmacokinetics subroutine for modeling double peak phenomenon. Biopharm Drug Dispos 27:119–124.
   PubMed Web of Science ®Google Scholar
• Miura M, Satoh S, Inoue K, et al. (2007). Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol 63:1161–1169.
   PubMed Web of Science ®Google Scholar
• Miyauchi S, Sawada Y, Iga T, et al. (1993). Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm Res 10:434–440.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kinouchi T, Mizukoshi H, Araki Y. (1974). Mode of estrogen conjugation and hepato-intestinal circulation: With special reference to man. Nihon Rinsho 32:3296–3301.
   PubMedGoogle Scholar
• Montagnani M, Aldini R, Roda A, et al. (1996). Species differences in hepatic bile acid uptake: Comparative evaluation of taurocholate and tauroursodeoxycholate extraction in rat and rabbit. Comp Biochem Physiol a Physiol 113:157–164.
   PubMed Web of Science ®Google Scholar
• Moon Yj, Sagawa K, Frederick K, et al. (2006). Pharmacokinetics and bioavailability of the isoflavone biochanin a in rats. AAPS J 8:E433–E442. [Pmc][https://doi.org/10.1208/Aapsj080351] [https://doi.org/17025260][pubmedMismatch]
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Blackman GL, Paull JD, Wolf LJ. (1981). Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section. Anesthesiology 54:474–480.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Kishimura K, Nagami T, et al. (2011). Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers. J Pharm Sci 100:3854–3861.
   PubMed Web of Science ®Google Scholar
• Mortimer PR, Mackie DB, Haynes S. (1969). Ampicillin levels in human bile in the presence of biliary tract disease. Br Med J 3:88–89.
   PubMed Web of Science ®Google Scholar
• Moseley RH. (1986). Mechanisms of bile formation and cholestasis: Clinical significance of recent experimental work. Am J Gastroenterol 81:731–735.
   PubMed Web of Science ®Google Scholar
• Moseley RH, Smit H, Van Solkema BG, et al. (1996). Mechanisms for the hepatic uptake and biliary excretion of tributylmethylammonium: studies with rat liver plasma membrane vesicles. J Pharmacol Exp Ther 276:561–567.
   PubMed Web of Science ®Google Scholar
• Munjal B, Pawar YB, Patel SB, Bansal AK. (2011). Comparative oral bioavailability advantage from curcumin formulations. Drug Deliv Transl Res 1:322–331.
   PubMed Web of Science ®Google Scholar
• Muraca M, Vilei MT, Miconi L, et al. (1991). A simple method for the determination of lipid composition of human bile. J Lipid Res 32:371–374.
   PubMed Web of Science ®Google Scholar
• Murata K, Noda K. (1993). Pharmacokinetic analysis of an oral sustained-release diltiazem preparation using multifraction absorption models. Pharm Res 10:757–762.
   PubMed Web of Science ®Google Scholar
• Murata K, Noda K, Kohno K, Samejima M. (1987). Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi-fraction absorption models. J Pharm Sci 76:109–113.
   PubMed Web of Science ®Google Scholar
• Murphy AA, Zacur HA, Charache P, Burkman RT. (1991). The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynecol 164:28–33.
   PubMed Web of Science ®Google Scholar
• Nayudu SK, Badipatla S, Niazi M, Balar B. (2013). Cholestatic hepatitis with small duct injury associated with celecoxib. Case Rep Med 2013:315479.
   PubMedGoogle Scholar
• Neugebauer G, Gabor M, Reiff K (1988). Pharmacokinetics and bioavailability of carvedilol in patients with liver cirrhosis. Drugs, 36,148–54
   PubMed Web of Science ®Google Scholar
• Nies AT, Koepsell H, Winter S, et al. (2009). Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227–1240.
   PubMed Web of Science ®Google Scholar
• Nishida K, Okazaki M, Sakamoto R, et al. (2007). Change in pharmacokinetics of model compounds with different elimination processes in rats during hypothermia. Biol Pharm Bull 30:1763–1767.
   PubMed Web of Science ®Google Scholar
• Norlin M, Andersson U, Bjorkhem I, Wikvall K. (2000). Oxysterol 7 alpha-hydroxylase activity by cholesterol 7 alpha-hydroxylase (CYP7A). J Biol Chem 275:34046–34053.
   PubMed Web of Science ®Google Scholar
• Nutescu EA, Shapiro NL. (2003). Ezetimibe: A selective cholesterol absorption inhibitor. Pharmacotherapy 23:1463–1474.
   PubMed Web of Science ®Google Scholar
• O'dwyer PJ, Szarka C, Brennan JM, et al. (2000). Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose. Clin Cancer Res 6:4692–4696.
   PubMed Web of Science ®Google Scholar
• O'maille ER, Richards TG, Short AH. (1967). The influence of conjugation of cholic acid on its uptake and secretion: Hepatic extraction of taurocholate and cholate in the dog. J Physiol 189:337–350.
   PubMed Web of Science ®Google Scholar
• Oberle RL, Amidon GL. (1987). The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. J Pharmacokinet Biopharm 15:529–544.
   PubMedGoogle Scholar
• Okusanya O, Forrest A, Difrancesco R, et al. (2007). Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother 51:1822–1826.
   PubMed Web of Science ®Google Scholar
• Orme ML, Back DJ. (1990). Factors affecting the enterohepatic circulation of oral contraceptive steroids. Am J Obstet Gynecol 163:2146–2152.
   PubMed Web of Science ®Google Scholar
• Oude Elferink RP, Meijer DK, Kuipers F, et al. (1995). Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215–268.
   PubMed Web of Science ®Google Scholar
• Oude Elferink RP, Ottenhoff R, Liefting WG, et al. (1990). ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. Am J Physiol 258:G699–G706.
   PubMed Web of Science ®Google Scholar
• Ouellet DM, Pollack GM. (1995). Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. Drug Metab Dispos 23:478–484.
   PubMed Web of Science ®Google Scholar
• Padda MS, Sanchez M, Akhtar AJ, Boyer JL. (2011). Drug-induced cholestasis. Hepatology 53:1377–1387.
   PubMed Web of Science ®Google Scholar
• Padowski JM, Pollack GM. (2012). Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in rats. Drug Metab Dispos 40:1846–1853.
   PubMed Web of Science ®Google Scholar
• Pang KS. (1995). Acinar factors in drug processing: protein binding, futile cycling, and cosubstrate. Drug Metab Rev 27:325–368.
   PubMed Web of Science ®Google Scholar
• Park SC, Chun HJ, Kang CD, Sul D. (2011). Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol 17:4647–4653.
   PubMed Web of Science ®Google Scholar
• Parker RJ, Hirom PC, Millburn P. (1980). Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat. Hydrolysis of glucuronic acid conjugates in the gut lumen. Xenobiotica 10:689–703.
   PubMed Web of Science ®Google Scholar
• Pastan I, Gottesman M. (1987). Multiple-drug resistance in human cancer. N Engl J Med 316:1388–1393.
   PubMed Web of Science ®Google Scholar
• Patel NJ, Zamek-Gliszczynski MJ, Zhang P, et al. (2003). Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. Mol Pharmacol 64:154–159.
   PubMed Web of Science ®Google Scholar
• Pauli-Magnus C, Meier PJ. (2005). Hepatocellular transporters and cholestasis. J Clin Gastroenterol 39:S103–S110.
   PubMed Web of Science ®Google Scholar
• Pauli-Magnus C, Meier PJ, Stieger B. (2010). Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. Semin Liver Dis 30:147–159.
   PubMed Web of Science ®Google Scholar
• Pawar YB, Munjal B, Arora S, et al. (2012). Bioavailability of a lipidic formulation of curcumin in healthy human volunteers. Pharmaceutics 4:517–530.
   PubMedGoogle Scholar
• Pedersen PV, Miller R. (1980). Pharmacokinetics and bioavailability of cimetidine in humans. J Pharm Sci 69:394–398.
   PubMed Web of Science ®Google Scholar
• Pena MA, Horga JF, Zapater P. (2016). Variations of pharmacokinetics of drugs in patients with cirrhosis. Expert Rev Clin Pharmacol 9:441–458.
   PubMed Web of Science ®Google Scholar
• Pentikainen PJ, Neuvonen PJ, Jostell KG. (1980). Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver. Eur J Clin Pharmacol 17:275–284.
   PubMed Web of Science ®Google Scholar
• Pescovitz MD, Bumgardner G, Gaston RS, et al. (2003). Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation. Clin Transplant 17:511–517.
   PubMed Web of Science ®Google Scholar
• Phillips J. (1991). Food and chemical toxicology. In: Haley TJ, Berndt WO, eds. Handbook of toxicology. Vol. 29. London: Hemisphere Publishing Corp., 135–136.
   Google Scholar
• Picard N, Premaud A, Rousseau A, et al. (2006). A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients. Br J Clin Pharmacol 62:477–484.
   PubMed Web of Science ®Google Scholar
• Ploeger BA, Meulenbelt J, Dejongh J. (2000). Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Toxicol Appl Pharmacol 162:177–188.
   PubMed Web of Science ®Google Scholar
• Plusquellec Y, Arnaud R, Saivin S, et al. (1998). Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaks. Arzneimittelforschung 48:138–144.
   PubMed Web of Science ®Google Scholar
• Plusquellec Y, Houin G. (1994). Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract. Arzneimittelforschung 44:679–682.
   PubMed Web of Science ®Google Scholar
• Prasad B, Evers R, Gupta A, et al. (2014). Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: Quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex. Drug Metab Dispos 42:78–88.
   PubMed Web of Science ®Google Scholar
• Prasad B, Lai Y, Lin Y, Unadkat JD. (2013). Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. J Pharm Sci 102:787–793.
   PubMed Web of Science ®Google Scholar
• Ranheim B, Ween H, Egeli AK, et al. (2002). Benzathine penicillin G and procaine penicillin G in piglets: Comparison of intramuscular and subcutaneous injection. Vet Res Commun 26:459–465.
   PubMed Web of Science ®Google Scholar
• Rath L, Hutchison M. (1989). A new method of bile duct cannulation allowing bile collection and re-infusion in the conscious rat. Lab Anim 23:163–168.
   PubMed Web of Science ®Google Scholar
• Repa JJ, Berge KE, Pomajzl C, et al. (2002). Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277:18793–18800.
   PubMed Web of Science ®Google Scholar
• Reshetnyak VI. (2013). Physiological and molecular biochemical mechanisms of bile formation. World J Gastroenterol 19:7341–7360.
   PubMed Web of Science ®Google Scholar
• Reuter BK, Davies NM, Wallace JL. (1997). Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112:109–117.
   PubMed Web of Science ®Google Scholar
• Reynolds KS, Song MH, Heizer WD, et al. (1998). Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans. Pharm Res 15:1281–1285.
   PubMed Web of Science ®Google Scholar
• Riippa P, Kauppila A, Sundstrom H, Vihko R. (1984). Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma. Anticancer Res 4:109–112.
   PubMed Web of Science ®Google Scholar
• Riond JL, Riviere JE. (1990). Pharmacokinetics and metabolic inertness of doxycycline in young pigs. Am J Vet Res 51:1271–1275.
   PubMed Web of Science ®Google Scholar
• Robert WK, Jr. (2014). Gastrointestinal toxicology. In: Hayes AW, Kruger CL, eds. Hayes' principles and methods of toxicology. Florida: CRC Press, 1521–1566.
   Google Scholar
• Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. (2002). Enterohepatic circulation: Physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751–790.
   PubMed Web of Science ®Google Scholar
• Robinson JD, Morris BA, Aherne GW, Marks V. (1975). Pharmacokinetics of a single dose of phenytoin in man measured by radioimmunoassay. Br J Clin Pharmacol 2:345–349.
   PubMed Web of Science ®Google Scholar
• Rollins DE, Klaassen CD. (1979). Biliary excretion of drugs in man. Clin Pharmacokinet 4:368–379.
   Google Scholar
• Rossi M, Vajro P, Iorio R, et al. (2005). Characterization of liver involvement in defects of cholesterol biosynthesis: Long-term follow-up and review. Am J Med Genet a 132A:144–151.
   PubMed Web of Science ®Google Scholar
• Roth A, Chakor K, Creppy EE, et al. (1988). Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicology 48:293–308.
   PubMed Web of Science ®Google Scholar
• Roth M, Obaidat A, Hagenbuch B. (2012). OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–1287.
   PubMed Web of Science ®Google Scholar
• Saitta KS, Zhang C, Lee KK, et al. (2014). Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: Mode of action and pharmacokinetics . Xenobiotica 44:28–35.
   PubMed Web of Science ®Google Scholar
• Sales JE, Sutcliffe M, O'grady F. (1972). Cephalexin levels in human bile in presence of biliary tract disease. Br Med J 3:441–443
   PubMed Web of Science ®Google Scholar
• Sarda S, Page C, Pickup K, et al. (2012). Diclofenac metabolism in the mouse: Novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry. Xenobiotica 42:179–194.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Suzuki H, Aoki J, et al. (2004). Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2. Mol Pharmacol 66:450–459.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Suzuki H, Ito K, et al. (2002). Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 277:6497–6503.
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Hunt RH. (2010). Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: Clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am 39:433–464.
   PubMed Web of Science ®Google Scholar
• Schaiquevich P, Niselman A, Rubio M. (2002a). Comparison of two compartmental models for describing ranitidine's plasmatic profiles. Pharmacol Res 45:399–405.
   PubMed Web of Science ®Google Scholar
• Schaiquevich P, Niselman A, Rubio M. (2002b). Importance of entero-salivary recirculation in paracetamol pharmacokinetics. Biopharm Drug Dispos 23:245–249.
   PubMed Web of Science ®Google Scholar
• Schiavon G, Eechoute K, Mathijssen RH, et al. (2012). Biliary excretion of imatinib and its active metabolite CGP74588 during severe hepatic dysfunction. J Clin Pharmacol 52:1115–1120.
   PubMed Web of Science ®Google Scholar
• Schjonsby H. (1989). Vitamin B12 absorption and malabsorption. Gut 30:1686–1691.
   PubMed Web of Science ®Google Scholar
• Schrenk D, Gant TW, Preisegger KH, et al. (1993). Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17:854–860.
   PubMed Web of Science ®Google Scholar
• Schroepfer GJ Jr. (2000). Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 80:361–554.
   PubMed Web of Science ®Google Scholar
• Schwarz M, Lund EG, Lathe R, et al. (1997). Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. J Biol Chem 272:23995–24001.
   PubMed Web of Science ®Google Scholar
• Schwenk M. (1980). Transport systems of isolated hepatocytes. Studies on the transport of biliary compounds. Arch Toxicol 44:113–126.
   PubMed Web of Science ®Google Scholar
• Scott DO, Lunte CE. (1993). In vivo microdialysis sampling in the bile, blood, and liver of rats to study the disposition of phenol. Pharm Res 10:335–342.
   PubMed Web of Science ®Google Scholar
• Sharifi M, Ghafourian T. (2014). Estimation of biliary excretion of foreign compounds using properties of molecular structure. AAPS J 16:65–78.
   PubMed Web of Science ®Google Scholar
• Sheikh-Bahaei S, Ropella GE, Hunt CA. (2006). In silico hepatocyte: Agent-based modeling of the biliary excretion of drugs in vitro. Simulat Ser 38:157.
   Google Scholar
• Sheng J, Tian X, Xu G, et al. (2015). The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism. Drug Metab Dispos 43:63–72.
   PubMed Web of Science ®Google Scholar
• Shepard TA, Lockwood GF, Aarons LJ, Abrahams ID. (1989). Mean residence time for drugs subject to enterohepatic cycling. J Pharmacokinet Biopharm 17:327–345.
   PubMedGoogle Scholar
• Shepard TA, Reuning RH, Aarons LJ. (1985). Estimation of area under the curve for drugs subject to enterohepatic cycling. J Pharmacokinet Biopharm 13:589–608.
   PubMedGoogle Scholar
• Sher A, Rahman A. (1994). Role of diet on the enterohepatic recycling of estrogen in women taking contraceptive pills. J Pak Med Assoc 44:213.
   PubMedGoogle Scholar
• Shichiri M, Fukai N, Kono Y, Tanaka Y. (2009). Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers. Cancer Res 69:4760–4768.
   PubMed Web of Science ®Google Scholar
• Shilling AD, Azam F, Kao J, Leung L. (2006). Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane. J Pharmacol Toxicol Methods 53:186–197.
   PubMedGoogle Scholar
• Shim CK, Hong JS. (1989). Inter- and intrasubject variations of ranitidine pharmacokinetics after oral administration to normal male subjects. J Pharm Sci 78:990–994.
   PubMed Web of Science ®Google Scholar
• Shitara Y, Maeda K, Ikejiri K, et al. (2013). Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: Their roles in hepatic clearance and intestinal absorption. Biopharm Drug Dispos 34:45–78.
   PubMed Web of Science ®Google Scholar
• Silva JM, Day SH, Nicoll-Griffith DA. (1999). Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem Biol Interact 121:49–63.
   PubMed Web of Science ®Google Scholar
• Silverman JA. (1999). Multidrug-resistance transporters. Pharm Biotechnol 12:353–386.
   PubMedGoogle Scholar
• Simonson SG, Raza A, Martin PD, et al. (2004). Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. Clin Pharmacol Ther 76:167–177.
   PubMed Web of Science ®Google Scholar
• Sjogren E, Bredberg U, Lennernas H. (2012). The pharmacokinetics and hepatic disposition of repaglinide in pigs: Mechanistic modeling of metabolism and transport. Mol Pharm 9:823–841.
   PubMed Web of Science ®Google Scholar
• Smak Gregoor PJ, Van Gelder T, Hesse CJ, et al. (1999). Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: A cross-sectional study. Nephrol Dial Transplant 14:706–708.
   PubMed Web of Science ®Google Scholar
• Smith MS, Verghese CP, Shand DG, Pritchett EL. (1983). Pharmacokinetic and pharmacodynamic effects of diltiazem. Am J Cardiol 51:1369–1374.
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13–58.
   PubMed Web of Science ®Google Scholar
• Steimer JL, Plusquellec Y, Guillaume A, Boisvieux JF. (1982). A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation. J Pharm Sci 71:297–302.
   PubMed Web of Science ®Google Scholar
• Stieger B, Fattinger K, Madon J, et al. (2000). Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422–430.
   PubMed Web of Science ®Google Scholar
• Stieger B, Meier PJ. (2011). Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 12:611–631.
   PubMed Web of Science ®Google Scholar
• Storstein L. (1975). Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites. Clin Pharmacol Ther 17:313–320.
   PubMed Web of Science ®Google Scholar
• Stoupi S, Williamson G, Viton F, et al. (2010). In vivo bioavailability, absorption, excretion, and pharmacokinetics of [14C]procyanidin B2 in male rats. Drug Metab Dispos 38:287–291.
   PubMed Web of Science ®Google Scholar
• Suttle AB, Brouwer KL. (1994). Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat. Drug Metab Dispos 22:224–232.
   PubMed Web of Science ®Google Scholar
• Suttle AB, Brouwer KL. (1995). Gastrointestinal transit and distribution of ranitidine in the rat. Pharm Res 12:1316–1322.
   PubMed Web of Science ®Google Scholar
• Suttle AB, Pollack GM, Brouwer KL. (1992). Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles. Pharm Res 9:350–356.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. (2003). ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 278:22644–22649.
   PubMed Web of Science ®Google Scholar
• Symonds HW, Prime GR, Pullar RA. (1994). Preliminary evidence for the enterohepatic circulation of progesterone in the pig. Br Vet J 150:585–593.
   PubMedGoogle Scholar
• Tan HH, Schiano T. (2012). Effects of liver disease on drug metabolism in humans. In: Lyubimov A, ed. Encyclopedia of drug metabolism and interactions. Hoboken: Wiley-Blackwell Inc, 3795–3840.
   Google Scholar
• Teng S, Piquette-Miller M. (2007). Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151:367–376.
   PubMed Web of Science ®Google Scholar
• Thomas C, Auwerx J, Schoonjans K. (2008). Bile acids and the membrane bile acid receptor TGR5 connecting nutrition and metabolism. Thyroid 18:167–174.
   PubMed Web of Science ®Google Scholar
• Thomas C, Gioiello A, Noriega L, et al. (2009). TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10:167–177.
   PubMed Web of Science ®Google Scholar
• Tomer G, Shneider BL. (2003). Disorders of bile formation and biliary transport. Gastroenterol Clin North Am 32:839–855, vi.
   PubMed Web of Science ®Google Scholar
• Toscano E, Cotta J, Robles M, et al. (2010). Hepatotoxicity induced by new immunosuppressants. Gastroenterol Hepatol 33:54–65.
   PubMed Web of Science ®Google Scholar
• Trauner M, Claudel T, Fickert P, et al. (2010). Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28:220–224.
   PubMed Web of Science ®Google Scholar
• Trauner M, Fickert P, Zollner G. (2001). Genetic disorders and molecular mechanisms in cholestatic liver disease – A clinical approach. Semin Gastrointest Dis 12:66–88.
   PubMedGoogle Scholar
• Trauner M, Wagner M, Fickert P, Zollner G. (2005). Molecular regulation of hepatobiliary transport systems: Clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39:S111–S124.
   PubMed Web of Science ®Google Scholar
• Tripathi KD. (2013). Introduction, routes of drug administration. In: Tripathi KD, ed. Essentials of medical pharmacology. New Delhi, India: Jaypee Publishers, 3–6.
   Google Scholar
• Tsai TH, Huang CT, Shum AY, Chen CF. (1999). Simultaneous blood and biliary sampling of esculetin by microdialysis in the rat. Life Sci 65:1647–1655.
   PubMed Web of Science ®Google Scholar
• Tse FL, Ballard F, Jaffe JM. (1982). A practical method for monitoring drug excretion and enterohepatic circulation in the rat. J Pharmacol Methods 7:139–144.
   PubMedGoogle Scholar
• Tubic M, Wagner D, Spahn-Langguth H, et al. (2006). Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. Eur J Pharm Sci 29:231–239.
   PubMed Web of Science ®Google Scholar
• Tvrdonova M, Dedik L, Mircioiu C, et al. (2009). Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings. Basic Clin Pharmacol Toxicol 104:35–42.
   PubMed Web of Science ®Google Scholar
• Van Den Broek MP, Groenendaal F, Egberts AC, Rademaker CM. (2010). Effects of hypothermia on pharmacokinetics and pharmacodynamics: A systematic review of preclinical and clinical studies. Clin Pharmacokinet 49:277–294.
   PubMed Web of Science ®Google Scholar
• Van Hest RM, Van Gelder T, Vulto AG, et al. (2009). Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients. Clin Pharmacokinet 48:463–476.
   PubMed Web of Science ®Google Scholar
• Van Wijk H, Donachie P, Mann DL, et al. (2001). A novel bile duct cannulation method with tail cuff exteriorization allowing continuous intravenous infusion and enterohepatic recirculation in the unrestrained rat. Lab Anim 35:325–333.
   PubMed Web of Science ®Google Scholar
• Varma MV, Lai Y, Kimoto E, et al. (2013). Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide. Pharm Res 30:1188–1199.
   PubMed Web of Science ®Google Scholar
• Verbeeck RK. (2008). Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64:1147–1161.
   PubMed Web of Science ®Google Scholar
• Veronese L, Rautaureau J, Sadler BM, et al. (2000). Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function. Antimicrob Agents Chemother 44:821–826.
   PubMed Web of Science ®Google Scholar
• Vonk RJ, Kneepkens CM, Havinga R, et al. (1986). Enterohepatic circulation in man. A simple method for the determination of duodenal bile acids. J Lipid Res 27:901–904.
   PubMed Web of Science ®Google Scholar
• Vonk RJ, Van Doorn AB, Strubbe JH. (1978). Bile secretion and bile composition in the freely moving, unanaesthetized rat with a permanent biliary drainage: Influence of food intake on bile flow. Clin Sci Mol Med 55:253–259.
   PubMedGoogle Scholar
• Vuoristo M, Miettinen TA. (1985). Increased biliary lipid secretion in celiac disease. Gastroenterology 88:134–142.
   PubMed Web of Science ®Google Scholar
• Wajima T, Yano Y, Oguma T. (2002). A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation. J Pharm Pharmacol 54:929–934.
   PubMed Web of Science ®Google Scholar
• Walkenstein SS, Dubb JW, Randolph WC, et al. (1978). Bioavailability of cimetidine in man. Gastroenterology 74:360–365.
   PubMed Web of Science ®Google Scholar
• Wallace JL. (2012). NSAID gastropathy and enteropathy: Distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol 165:67–74.
   PubMed Web of Science ®Google Scholar
• Wang Y, Roy A, Sun L, Lau CE. (1999). A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration. Drug Metab Dispos 27:855–859.
   PubMed Web of Science ®Google Scholar
• Wang YM, Reuning RH. (1994). A comparison of two surgical techniques for preparation of rats with chronic bile duct cannulae for the investigation of enterohepatic circulation. Lab Anim Sci 44:479–485.
   PubMedGoogle Scholar
• Watanabe T, Suzuki H, Sawada Y, et al. (1995). Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J Hepatol 23:440–448.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kusuhara H, Maeda K, et al. (2008). Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 23:440–448.
   Google Scholar
• Webborn PJ, Parker AJ, Denton RL, Riley RJ. (2007). In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects. Xenobiotica 37:1090–1109.
   PubMed Web of Science ®Google Scholar
• Wenzel E, Somoza V. (2005). Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472–481.
   PubMed Web of Science ®Google Scholar
• West WL, Cheatham LR, Gaillard ET, Wright M. (2002). A chronic bile duct and intravenous cannulation model in conscious rabbits for pharmacokinetic studies. J Invest Surg 15:81–89.
   PubMed Web of Science ®Google Scholar
• Westphal JF, Brogard JM, Caro-Sampara F, et al. (1997). Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother 41:1636–1640.
   PubMed Web of Science ®Google Scholar
• Wigg AJ, Barritt GJ, Young GP, Phillips JW. (2009). Inhibition of oxidative stress and apoptosis enables extended maintenance of integrity and function of isolated hepatocytes in suspension. J Gastroenterol Hepatol 24:1082–1088.
   PubMed Web of Science ®Google Scholar
• Williams RT, Millburn P, Smith RL. (1965). The influence of enterohepatic circulation on toxicity of drugs. Ann NY Acad Sci 123:110–124.
   PubMed Web of Science ®Google Scholar
• Wilson CG. (2000). Gastrointestinal transit and drug absorption. In: Dressman JB, Lennernäs H, eds. Oral drug absorption: Prediction and assessment. New York: Marcel Decker, Inc., 1–17.
   Google Scholar
• Wolkoff AW, Samuelson AC, Johansen KL, et al. (1987). Influence of Cl- on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest 79:1259–1268.
   PubMed Web of Science ®Google Scholar
• Xie R, Mathijssen RH, Sparreboom A, et al. (2002). Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea. Clin Pharmacol Ther 72:265–275.
   PubMed Web of Science ®Google Scholar
• Xing J, Chen X, Zhong D. (2005). Absorption and enterohepatic circulation of baicalin in rats. Life Sci 78:140–146.
   PubMed Web of Science ®Google Scholar
• Xu R, Wang Q, Zhang J, et al. (2014). Changes in pharmacokinetic profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either glycyrrhizin, silibinin or spironolactone in rat. Xenobiotica 44:541–546.
   PubMed Web of Science ®Google Scholar
• Yabe Y, Galetin A, Houston JB. (2011). Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808–1814.
   PubMed Web of Science ®Google Scholar
• Yabuuchi H, Tanaka K, Maeda M, et al. (2008). Cloning of the dog bile salt export pump (BSEP; ABCB11) and functional comparison with the human and rat proteins. Biopharm Drug Dispos 29:441–448.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Oida T, Ikeda C, Sekine Y. (1986). Intestinal absorption of a beta-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats. Chem Pharm Bull (Tokyo) 34:4259–4264.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Kubota Y, Takaoka M, et al. (2002). The effect of biliary decompression on antibiotic biliary excretion. Hepatogastroenterology 49:330–334.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Suzuki H, Sugiyama Y. (1996). Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13:497–513.
   PubMed Web of Science ®Google Scholar
• Yeomans ND, Vajda FJ, Baldas J. (1982). Bioavailability of valproate after gastric and direct intestinal administration in rats. Clin Exp Pharmacol Physiol 9:173–177.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Maeda K, Sugiyama Y. (2013). Hepatic and intestinal drug transporters: Prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annu Rev Pharmacol Toxicol 53:581–612.
   PubMed Web of Science ®Google Scholar
• Younis IR, Malone S, Friedman HS, et al. (2009). Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma. Cancer Chemother Pharmacol 63:517–524.
   PubMed Web of Science ®Google Scholar
• Yu L, Hammer RE, Li-Hawkins J, et al. (2002). Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237–16242.
   PubMed Web of Science ®Google Scholar
• Zhang YK, Guo GL, Klaassen CD. (2011). Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PLoS One 6:e16683.
   PubMed Web of Science ®Google Scholar
• Zhou HW, Shen JQ, Lu M, et al. (1992). Pharmacokinetic analysis of enterohepatic circulation of piroxicam in rabbits. Zhongguo Yao Li Xue Bao 13:180–182.
   PubMed Web of Science ®Google Scholar
• Zucker SD, Goessling W, Gollan JL. (1996). Intracellular transport of small hydrophobic compounds by the hepatocyte. Semin Liver Dis 16:159–167.
   PubMed Web of Science ®Google Scholar